½ÃÀ庸°í¼­
»óǰÄÚµå
1605767

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : À¯·¡º°, °æ·Îº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)

Hydrogel-Based Drug Delivery System Market, By Origin, By Route, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 260 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2023³â 74¾ï 5,500¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.4% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå - ½ÃÀå ¿ªÇÐ

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡¼­ ¾à¹° ¹æÃâÀÇ Ç¥ÀûÈ­ ¹× Á¦¾î¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¾à¹° ¹æÃâ Ç¥ÀûÈ­ ¹× Á¦¾î ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ¾à¹°À» ĸ½¶È­Çϰí Á¦¾îµÈ ¼Óµµ·Î ¾à¹°À» ¹æÃâÇÏ´Â ÇÏÀ̵å·Î°ÖÀÇ °íÀ¯ÇÑ ´É·ÂÀº ƯÈ÷ ¸¸¼ºÁúȯ °ü¸®¿¡¼­ Ä¡·á È¿°ú¸¦ ³ôÀÔ´Ï´Ù. ÀÌ ±â¼úÀº Á¤È®¼º°ú ºÎÀÛ¿ëÀÌ Àû±â ¶§¹®¿¡ Á¾¾çÇÐ, ´ç´¢º´ ¹× »óó Ä¡·á¿¡¼­ ƯÈ÷ ³ôÀº Æò°¡¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¬±¸ ÀÚ±ÝÀÇ Áõ°¡¿Í »ýºÐÇØ¼º ¹× »ýü ¹ÝÀÀ¼º ÇÏÀ̵å·Î°ÖÀÇ °³¹ß·Î ¿ëµµ°¡ È®´ëµÇ¸é¼­ ÀÌ Çõ½ÅÀûÀÎ ¾à¹°Àü´Þ ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¿¬±¸ ºÐ¼®°¡µéÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¸Å³â ¾à 6.4%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯·¡º°·Î´Â ÇÕ¼º ÇÏÀ̵å·Î°ÖÀÌ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

°æ·Îº°·Î´Â 2023³â ±¹¼Ò Åõ¿©°¡ ÁÖ¿ä À¯ÇüÀ¸·Î ºÎ»óÇß½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀ̾ú½À´Ï´Ù.

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº À¯·¡, °æ·Î ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù. À¯·¡ ±âÁØ: õ¿¬, ÇÕ¼º ¹× ÇÏÀ̺긮µå ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡¼­ ÇÕ¼º ÇÏÀ̵å·Î°ÖÀº ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå, Æú¸®¿¡Æ¿·» ±Û¸®ÄÝ(PEG), Æú¸®ºñ´Ò ¾ËÄÚ¿Ã(PVA)°ú °°Àº Àç·á·Î ¸¸µç ÇÕ¼º ÇÏÀ̵å·Î °ÖÀº õ¿¬ ÇÏÀ̵å·Î °Ö¿¡ ºñÇØ È­ÇÐ ¼ººÐ, ±â°èÀû °­µµ ¹× ºÐÇØ ¼Óµµ¸¦ ´õ Àß Á¦¾î ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦¾î´Â Á¤È®ÇÑ ¾à¹° ¹æÃâÀ» °¡´ÉÇÏ°Ô ÇÏ¿© º¹ÀâÇÑ Ä¡·á ¿ëµµ¿¡ ¸Å¿ì ¹Ù¶÷Á÷ÇÕ´Ï´Ù. Äݶó°Õ, ŰÅä»ê µî õ¿¬ ÇÏÀ̵å·Î°ÖÀº »ýüÀûÇÕ¼º ¶§¹®¿¡ ÀαⰡ ³ôÁö¸¸, ÇÕ¼º ÇÏÀ̵å·Î°ÖÀº ´ÙÀç´Ù´ÉÇÏ°í °í±Þ ¾à¹°Àü´Þ¿¡¼­ ¼º´ÉÀÌ Çâ»óµÇ¾î ´õ ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù.

°æ·Îº°·Î´Â ÇÇÇÏ, ´«, ±¸°­, ±¹¼Ò, ±âŸ. ÇöÀç ±¹¼Ò Àü´ÞÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ °æ·Î´Â ÇÏÀ̵å·Î°ÖÀÌ ¾à¹°À» ±¹¼ÒÀûÀ¸·Î Áö¼ÓÀûÀ¸·Î ¹æÃâÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ÇǺΠÀû¿ë, »óó Ä¡·á, ±¹¼Ò ÅëÁõ ¿ÏÈ­ µî¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ±¹¼Ò ÇÏÀ̵å·Î°ÖÀº ¶ÇÇÑ ÁøÁ¤ È¿°ú°¡ ÀÖ°í ºñħ½ÀÀûÀ̸ç Àû¿ëÀÌ ¿ëÀÌÇÏ¿© ȯÀÚÀÇ Æí¾ÈÇÔ°ú ¼øÀÀµµ¸¦ Çâ»ó½Ãŵ´Ï´Ù. ÇǺΰú Ä¡·á¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä¿Í ¸¸¼º »óóÀÇ Áõ°¡·Î ÀÎÇØ ÇÏÀ̵å·Î°Ö ±¹¼Ò ¾à¹°Àü´Þ¿¡ ´ëÇÑ ¼±È£µµ°¡ ´õ¿í ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀº Àü ¼¼°èÀûÀ¸·Î È®´ëµÇ°í ÀÖÀ¸¸ç, ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ Å« ¿òÁ÷ÀÓÀ» º¸À̰í ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ³ôÀº °ü½É, Çõ½ÅÀûÀÎ ¾à¹°Àü´Þ ¹æ½Ä¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ ÇöÀç ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº ÇÏÀ̵å·Î°ÖÀÇ Ä¡·á °¡´É¼º¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ¿¬±¸¸¦ ¹ÙÅÁÀ¸·Î ÇÏÀ̵å·Î°Ö äÅ÷ü¿¡¼­ ¼±µÎ¸¦ ´Þ¸®°í ÀÖ½À´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄɾ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ¸¸¼ºÁúȯÀÇ Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, ÀÌ ½ÃÀå¿¡¼­ Áß¿äÇÑ ½ÅÈï Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå - °æÀï »óȲ:

ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϸç, ÁÖ¿ä ±â¾÷µéÀº Çõ½Å°ú Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ ÁßÁ¡À» µÎ°í Á¦Ç° Á¦°øÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. Johnson & Johnson, Allergan, Bayer AG¿Í °°Àº ±â¾÷µéÀº ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇÏ¿© Ç¥Àû ¾à¹° ¹æÃâ ¹× Áö¼ÓÀû ¾à¹° ¹æÃâÀ» À§ÇÑ ÇÏÀ̵å·Î°Ö Á¦Á¦ÀÇ °³¼±À» À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. Ashland Inc. ¹× InnoCore Technologies¿Í °°Àº Áß¼Ò±â¾÷µéµµ Æ´»õ Ä¡·á ºÐ¾ß¿¡ ƯȭµÈ ÇÏÀ̵å·Î°Ö ¼Ö·ç¼ÇÀ¸·Î ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾àȸ»ç¿Í ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ÀÇ Çù¾÷Àº »ýü ¹ÝÀÀ¼º ÇÏÀ̵å·Î°Ö°ú »ýºÐÇØ¼º ÇÏÀ̵å·Î°ÖÀÇ ¹ßÀüÀ» ÃËÁøÇÏ°í ´Ù¾çÇÑ ÀÇ·á ÀÀ¿ë ºÐ¾ß¿¡¼­ ¾à¹°À» È¿°úÀûÀ¸·Î Àü´ÞÇÒ ¼ö ÀÖ´Â ½ÃÀåÀÇ °¡´É¼ºÀ» ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤ ¿¬µµ

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ³»¿ª
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ½ÃÀå Àü¸Á µ¿Çâ

Á¦4Àå ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ »ê¾÷ ¿¬±¸

  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ºÐ¼®

Á¦5Àå ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
  • COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå »óȲ

  • ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • ÁÖ¿ä Á¦Á¶¾÷üº° ³»¿ª µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ ºÐ¼®
    • ½ÅÈï ±â¾÷ ºÐ¼®

Á¦7Àå ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå - À¯·¡º°

  • °³¿ä
    • ºÎ¹® Á¡À¯À² ºÐ¼®
    • õ¿¬
    • ÇÕ¼º
    • ÇÏÀ̺긮µå

Á¦8Àå ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå - ·çÆ®º°

  • °³¿ä
    • ºÎ¹® Á¡À¯À² ºÐ¼®
    • ÇÇÇÏ
    • ¾È±¸
    • ±¸°­
    • ±¹¼Ò¿Í ±âŸ
    • ±âŸ

Á¦9Àå ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå - Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÇÏÀ̵å·Î°Ö ±â¹Ý ¾à¹°Àü´Þ ½Ã½ºÅÛ ¾÷°è

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä
    • Johnson & Johnson
    • Medtronic
    • F. Hoffmann-La Roche Ltd
    • Bayer AG
    • Pfizer Inc.
    • Amgen Inc.
    • Abbott Laboratories
    • Becton, Dickinson and Company(BD)
    • Biogelx Ltd
    • Akina, Inc.
    • Others

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm 24.12.20

REPORT HIGHLIGHT

Hydrogel-Based Drug Delivery System Market size was valued at USD 7,455 million in 2023, expanding at a CAGR of 6.4% from 2024 to 2032.

Hydrogel-based drug delivery systems are an innovative approach for controlled, targeted drug release in medical treatments. Composed of water-rich, biocompatible polymers, hydrogels can encapsulate therapeutic agents, allowing for gradual, localized release. Their porous structure enables precise dosing, enhancing drug efficacy while reducing side effects. Hydrogels are particularly advantageous in treating chronic conditions, as they can be tailored to respond to environmental triggers like pH and temperature. This adaptability makes hydrogel systems a promising solution for improving patient outcomes across various medical applications, including cancer, wound healing, and pain management.

Hydrogel-Based Drug Delivery System Market- Market Dynamics

Increasing Demand for Targeted and Controlled Drug Release in Hydrogel-Based Drug Delivery Systems

A primary driver of the Hydrogel-Based Drug Delivery System Market is the increasing demand for targeted and controlled drug release technologies. Hydrogels' unique ability to encapsulate drugs and release them at controlled rates enhances treatment effectiveness, particularly in chronic disease management. This technology is especially valued in oncology, diabetes, and wound care for its precision and minimal side effects. Additionally, rising research funding and the development of biodegradable and bioresponsive hydrogels are expanding applications, fueling further growth in this innovative drug delivery market.

Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.4% over the forecast period (2024-2032)

Based on Origin segmentation, Synthetic hydrogel was predicted to show maximum market share in the year 2023

Based on Route segmentation, Topical delivery was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Hydrogel-Based Drug Delivery System Market- Segmentation Analysis:

The Global Hydrogel-Based Drug Delivery System Market is segmented based on Origin, Route, and region. Based on Origin: Natural, Synthetic and Hybrid. In hydrogel-based drug delivery systems, synthetic hydrogels dominate the market. Synthetic hydrogels, derived from materials like polyacrylamide, polyethylene glycol (PEG), and polyvinyl alcohol (PVA), offer greater control over chemical composition, mechanical strength, and degradation rates compared to natural hydrogels. This control enables precise drug release, making them highly desirable for complex therapeutic applications. While natural hydrogels, derived from sources like collagen and chitosan, are popular for their biocompatibility, synthetic options are more widely adopted due to their versatility and enhanced performance in advanced drug delivery

Based on Route: Subcutaneous, Ocular, Oral Cavity, Topical and Other. Topical delivery currently dominates the market. This route benefits from hydrogel's ability to provide localized, sustained release of drugs, making it ideal for skin applications, wound care, and localized pain relief. Topical hydrogels also improve patient comfort and compliance due to their soothing, non-invasive nature and ease of application. The high demand for dermatological treatments and the rising prevalence of chronic wounds further drives the preference for topical hydrogel-based drug delivery.

Hydrogel-Based Drug Delivery System Market- Geographical Insights

The Hydrogel-Based Drug Delivery System Market is expanding globally, with significant activity across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America currently dominates this market due to its advanced healthcare infrastructure, strong focus on R&D, and high prevalence of chronic diseases that drive the demand for innovative drug delivery methods. The United States, in particular, leads in adoption, supported by extensive research on hydrogels' therapeutic potential. Meanwhile, Asia-Pacific is experiencing rapid growth, fueled by increased investments in healthcare and rising incidences of chronic illnesses, positioning it as a key emerging region in this market.

Hydrogel-Based Drug Delivery System Market- Competitive Landscape:

The Hydrogel-Based Drug Delivery System market is competitive, with key players focusing on innovation and strategic partnerships to enhance their product offerings. Companies such as Johnson & Johnson, Allergan, and Bayer AG are investing in research and development to improve hydrogel formulations for targeted and sustained drug release. Smaller firms like Ashland Inc. and InnoCore Technologies also contribute with specialized hydrogel solutions for niche therapeutic areas. Additionally, collaborations between pharmaceutical and biotechnology companies are driving advancements in bioresponsive and biodegradable hydrogels, broadening the market's potential in delivering drugs effectively across various medical applications.

Recent Developments:

In July 2023, Bausch + Lomb launched Infuse Multifocal Silicone Hydrogel Contact Lenses in the U.S. market. Utilizing silicone hydrogel (SiHy) technology minimizes the trade-off between oxygen permeability and wettability, enhancing long-term comfort and usability for consumers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Johnson & Johnson
  • Medtronic
  • F. Hoffmann-La Roche Ltd
  • Bayer AG
  • Pfizer Inc.
  • Amgen Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • Biogelx Ltd
  • Akina, Inc.
  • Others

GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, BY ORIGIN- MARKET ANALYSIS, 2019 - 2032

  • Natural
  • Synthetic
  • Hybrid

GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, BY ROUTE- MARKET ANALYSIS, 2019 - 2032

  • Subcutaneous
  • Ocular
  • Oral Cavity
  • Topical and Other
  • Others

GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hydrogel-based Drug Delivery System Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hydrogel-based Drug Delivery System Market Snippet by Origin
    • 2.1.2. Hydrogel-based Drug Delivery System Market Snippet by Route
    • 2.1.3. Hydrogel-based Drug Delivery System Market Snippet by Country
    • 2.1.4. Hydrogel-based Drug Delivery System Market Snippet by Region
  • 2.2. Competitive Insights

3. Hydrogel-based Drug Delivery System Key Market Trends

  • 3.1. Hydrogel-based Drug Delivery System Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hydrogel-based Drug Delivery System Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hydrogel-based Drug Delivery System Market Opportunities
  • 3.4. Hydrogel-based Drug Delivery System Market Future Trends

4. Hydrogel-based Drug Delivery System Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hydrogel-based Drug Delivery System Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hydrogel-based Drug Delivery System Market Landscape

  • 6.1. Hydrogel-based Drug Delivery System Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hydrogel-based Drug Delivery System Market - By Origin

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Origin, 2023 & 2032 (%)
    • 7.1.2. Natural
    • 7.1.3. Synthetic
    • 7.1.4. Hybrid

8. Hydrogel-based Drug Delivery System Market - By Route

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route, 2023 & 2032 (%)
    • 8.1.2. Subcutaneous
    • 8.1.3. Ocular
    • 8.1.4. Oral Cavity
    • 8.1.5. Topical and Other
    • 8.1.6. Others

9. Hydrogel-based Drug Delivery System Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Hydrogel-based Drug Delivery System Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Hydrogel-based Drug Delivery System Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Hydrogel-based Drug Delivery System Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Hydrogel-based Drug Delivery System Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Hydrogel-based Drug Delivery System Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Origin, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Route, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hydrogel-based Drug Delivery System Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Johnson & Johnson
    • 10.2.2. Medtronic
    • 10.2.3. F. Hoffmann-La Roche Ltd
    • 10.2.4. Bayer AG
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Amgen Inc.
    • 10.2.7. Abbott Laboratories
    • 10.2.8. Becton, Dickinson and Company (BD)
    • 10.2.9. Biogelx Ltd
    • 10.2.10. Akina, Inc.
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦